Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 8296

1.

Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: A systematic review and meta-analysis.

Dasari BVM, Ionescu MI, Pawlik TM, Hodson J, Sutcliffe RP, Roberts KJ, Muiesan P, Isaac J, Marudanayagam R, Mirza DF.

J Surg Oncol. 2018 Sep;118(3):477-485. doi: 10.1002/jso.25186. Review.

PMID:
30259519
2.

The optimal anticoagulant therapy for mechanical heart valves in a gallbladder cancer patient with hepatic metastases: A case report.

Yan YD, Su YJ, Chen BY, Cui JJ, Zhang ZL, Xu Q, Gu ZC.

Medicine (Baltimore). 2018 Sep;97(37):e12368. doi: 10.1097/MD.0000000000012368.

3.

[Establishment of Cas9 stably expressed human hepatocellular carcinoma and cholangiocarcinoma cell lines].

Zuo CX, Bian XC, Yang ZL, Feng HL, Zhou FY, Liu YQ.

Zhonghua Zhong Liu Za Zhi. 2018 Aug 23;40(8):572-579. doi: 10.3760/cma.j.issn.0253-3766.2018.08.003. Chinese.

PMID:
30139026
4.
5.

Long-term outcomes and prognostic markers in gallbladder cancer.

Cui X, Zhu S, Tao Z, Deng X, Wang Y, Gao Y, Liao Y, Ma W, Zhang Y, Ma X.

Medicine (Baltimore). 2018 Jul;97(28):e11396. doi: 10.1097/MD.0000000000011396.

6.

Is Hepatopancreatoduodenectomy an Acceptable Operation for Biliary Cancer?

Lee EC, Han SS, Lee SD, Park SJ.

Am Surg. 2018 May 1;84(5):703-711.

PMID:
29966572
7.

Computed Tomographic Features of Primary Small Cell Neuroendocrine Tumors of the Gallbladder.

Faraoun SA, Guerrache Y, Dautry R, Boudiaf M, Dohan A, Barral M, Hoeffel C, Rousset P, Fohlen A, Soyer P.

J Comput Assist Tomogr. 2018 Sep/Oct;42(5):707-713. doi: 10.1097/RCT.0000000000000753.

PMID:
29901505
8.

The prognostic value of preoperative inflammatory indexes in gallbladder carcinoma with hepatic involvement.

Tao Z, Li SX, Cui X, Huang Y, Zhu S, Wang Y, Tan H, Ma X.

Cancer Biomark. 2018;22(3):551-557. doi: 10.3233/CBM-181230.

PMID:
29865040
9.

Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2/9 through the PI3K/Akt signaling pathway.

Li H, Zhang Y, Hai J, Wang J, Zhao B, Du L, Geng X.

Biomed Pharmacother. 2018 Jul;103:1272-1278. doi: 10.1016/j.biopha.2018.04.120. Epub 2018 May 7.

PMID:
29864908
10.
11.

Pathogenesis of gallbladder adenomyomatosis and its relationship with early-stage gallbladder carcinoma: an overview.

Pang L, Zhang Y, Wang Y, Kong J.

Braz J Med Biol Res. 2018;51(6):e7411. doi: 10.1590/1414-431x20187411. Epub 2018 May 21. Review.

12.

Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium.

Lopez-Aguiar AG, Ethun CG, McInnis MR, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal EW, Hatzaras I, Shenoy R, Cardona K, Maithel SK.

J Surg Oncol. 2018 Jun;117(8):1638-1647. doi: 10.1002/jso.25086. Epub 2018 May 14.

PMID:
29761515
13.

The emerging roles of long non-coding RNA in gallbladder cancer tumorigenesis.

Chen B, Li Y, He Y, Xue C, Xu F.

Cancer Biomark. 2018;22(3):359-366. doi: 10.3233/CBM-170979. Review.

PMID:
29758925
14.

Tumor-infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer.

Wang J, Bo X, Suo T, Liu H, Ni X, Shen S, Li M, Xu J, Liu H, Wang Y.

Cancer Sci. 2018 Jul;109(7):2266-2274. doi: 10.1111/cas.13627. Epub 2018 May 26.

15.

The association between preoperative serum interleukin-6 levels and postoperative prognosis in patients with T2 gallbladder cancer.

Wang J, Liu J, Chang Q, Yang B, Li S, Gu C.

J Surg Oncol. 2018 Jun;117(8):1672-1678. doi: 10.1002/jso.25085. Epub 2018 May 3.

PMID:
29723410
16.

Gallbladder carcinoma: An analysis of the national cancer data base to examine hispanic influence.

Liu C, Berger NG, Rein L, Tarima S, Clarke C, Mogal H, Christians KK, Tsai S, Gamblin TC.

J Surg Oncol. 2018 Jun;117(8):1664-1671. doi: 10.1002/jso.25050. Epub 2018 May 1.

PMID:
29714811
17.

Clues to predict incidental gallbladder cancer.

Goussous N, Maqsood H, Patel K, Ferdosi H, Muhammad N, Sill AM, Kowdley GC, Cunningham SC.

Hepatobiliary Pancreat Dis Int. 2018 Apr;17(2):149-154. doi: 10.1016/j.hbpd.2018.02.001. Epub 2018 Feb 19.

PMID:
29709218
18.

c‑Jun suppresses the expression of WNT inhibitory factor 1 through transcriptional regulation and interaction with DNA methyltransferase 1 in gallbladder cancer.

Lin B, Hong H, Jiang X, Li C, Zhu S, Tang N, Wang X, She F, Chen Y.

Mol Med Rep. 2018 Jun;17(6):8180-8188. doi: 10.3892/mmr.2018.8890. Epub 2018 Apr 16.

19.

Metagenomics of Microbial Communities in Gallbladder Bile from Patients with Gallbladder Cancer or Cholelithiasis

Tsuchiya Y, Loza E, Villa-Gomez G, Trujillo CC, Baez S, Asai T, Ikoma T, Endoh K, Nakamura K.

Asian Pac J Cancer Prev. 2018 Apr 25;19(4):961-967.

20.

Diagnostic accuracy of MDCT in differentiating gallbladder cancer from acute and xanthogranulomatous cholecystitis.

Wasnik AP, Davenport MS, Kaza RK, Weadock WJ, Udager A, Keshavarzi N, Nan B, Maturen KE.

Clin Imaging. 2018 Jul - Aug;50:223-228. doi: 10.1016/j.clinimag.2018.04.010. Epub 2018 Apr 14.

PMID:
29679780

Supplemental Content

Loading ...
Support Center